Skip to main content
. 2014 Jan 16;13:5. doi: 10.1186/1475-2891-13-5

Table 1.

Participant demographics, medications, and disease indices

Age Sex Disease Prior treatment includes Recent treatment HBI/MTLWSI before HBI/MTLWSI after
39
F
CD
ASA, IM, B
ASA?+?IBD-AID
HBI
12
3
47
F
CD
S, IM, B
S(taper)?+?IBD-AID
HBI
9
2
39
F
CD
S,IM
IM?+?IBD-AID
HBI
12
2
24
F
CD
S,ASA, IM, B
S(taper) IM?+?IBD-AID
HBI
15
0
39
M
CD
IM, B
IBD?+?AID
HBI
20
0
40
M
CD
S,ASA, IM
IM?+?IBD-AID
HBI
15
2
41
M
CD
ASA, IM
IM?+?IBD-AID
HBI
4
2
37
F
CD
S,ASA, B, elemental diet
B?+?IBD-AID
HBI
1
1; histologic remission
69
M
UC
ASA, IM, B
ASA, IM?+?IBD-AID
MTLWSI n/d
2; improved
19
F
UC
S, ASA, IM, B
ASA, IBD-AID
MTLWSI 6
0
70 F UC ASA, IM, B B?+?IBD-AID MTLWSI 8 0

Legend:

ASA?=?5-Aminosalycylic acid agent.

IM?=?Immunomodulator.

B?=?Biologic.

S?=?Steroid.

IBD-AID?=?Inflammatory Bowel Disease-Anti-Inflammatory Diet.

HBI?=?Harvey Bradshaw Index.

MTLWSISI?=?Modified TrueLove and Witts Severity Index.